759916AD1

Repligen Corp

Could not find a ticker for this position, may be a filing error

A maker of tools and consumables for biologic drug manufacturing, Repligen supplies cell-retention filters, pre-packed columns, purification resins, and growth factors used by drugmakers worldwide. Founded in 1981 in Cambridge, Massachusetts, by two molecular biology professors, it focused entirely on bioprocessing starting in 2012. Its name blends "replication" and "genetics," a nod to its roots in recombinant protein science.

1.00% Convertible Senior Notes due December 15, 2028